NASDAQ:SEER Seer Q3 2026 Earnings Date & Estimates $1.79 +0.06 (+3.41%) As of 09:37 AM Eastern This is a fair market value price provided by Massive. Learn more. Seer is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 10, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Seer in Q3 2026Seer is expected to post earnings of -$0.26 per share on revenue of $4.15 million. In the same quarter a year earlier Seer reported -$0.32 per share on revenue of $4.12 million. Seer last reported on August 11, 2026, posting -$0.31 per share and missing the -$0.27 consensus estimate. Seer has beaten the consensus EPS estimate in 5 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.26Expected Revenue$4.15 millionPrior-Year EPS-$0.32Prior-Year Revenue$4.12 millionExpected Revenue Growth+0.7%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.31 (Missed by -$0.04)Last Quarter Revenue$3.10 millionEPS Beat Rate5 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Seer Q3 2026 Earnings FAQ When does Seer report Q3 2026 earnings? Seer (NASDAQ:SEER) is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Seer's Q3 2026 earnings call? Seer's Q3 2026 earnings conference call is scheduled for Tuesday, November 10, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Seer? Analysts expect Seer to post earnings of -$0.26 per share for Q3 2026. How much revenue is Seer expected to report? The consensus revenue estimate for Seer is $4.15 million for Q3 2026. Seer Earnings HeadlinesSeer, Inc. special committee rejects unsolicited acquisition proposals of $2.55 and $2.45 per share1 hour ago | msn.comRadoff-JEC Group Issues Open Letter Condemning Seer’s Unexplained and Seemingly Illogical Decision to Remain a Public CompanyNovember 2 at 4:25 PM | finance.yahoo.comU.S. Army Advances 75-Year Rare Earth Deal With Nasdaq FirmThe Pentagon is moving to cut US dependence on Chinese rare earth metals, and a Nasdaq-listed company just signed a term sheet for a potential 75-year agreement with the US Army. The proposed deal would let the company build and operate a rare earth processing facility on an active military base, with the Army getting first right to production. New Pentagon restrictions on Chinese-origin rare earth magnets take effect January 1, 2027. The company's mine-to-magnet platform covers feedstock agreements, processing, metallization, and downstream manufacturing, with commercial output targeted for 2027.November 3 at 1:00 AM | The Tomorrow Investor (Ad)Seer Board Rejects Acquisition Offers, Remains IndependentOctober 29, 2026 | tipranks.comSeer to Remain an Independent Public Company Following Conclusion of Special Committee Review ProcessOctober 29, 2026 | globenewswire.comSeer to Report Third Quarter 2026 Financial Results on November 10, 2026October 21, 2026 | globenewswire.comSee More Seer Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Seer? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Seer and other key companies, straight to your email. Email Address About SeerSeer (NASDAQ:SEER) is a life sciences company that develops technologies for large-scale protein analysis, known as proteomics. The company’s platform is designed to help researchers study a broad range of proteins in biological samples and generate detailed information that may support drug discovery, disease research and biomarker development. Seer’s primary offering is the Proteograph Product Suite, which combines engineered nanoparticle technology, laboratory consumables, automation and software. The system is intended to provide deep, unbiased proteomic analysis from relatively small biological samples, including blood and other complex specimens. The company serves pharmaceutical and biotechnology companies, academic and research institutions, and other organizations involved in life sciences research. Seer is headquartered in Redwood City, California, and its products are marketed for research applications in domestic and international markets.View Seer ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Check Point's Turnaround Could Be Closer Than Investors ThinkAbbVie's Humira Era Is Fading, But Its New Growth Engines Face Another TestAlphabet’s $400 Billion Sell-Off Could Be the Best AI Buying Window Left in 2026Exxon's Refining Profits Soared—Did Chevron Get the Same Windfall?LyondellBasell's Dividend Looks Safer, But a New Risk Could Change ThatUranium Prices Are Near Historic Highs—So Why Hasn’t Cameco Followed?Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts? Upcoming Earnings McDonald's (11/4/2026)DoorDash (11/4/2026)MercadoLibre (11/4/2026)Cenovus Energy (11/4/2026)Aflac (11/4/2026)Allstate (11/4/2026)MetLife (11/4/2026)Manulife Financial (11/4/2026)Cencora (11/4/2026)CVS Health (11/4/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.